Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

Eric Chun Yet Lian; Andreas G. Tzakis; David Andrews

doi:10.1002/ajh.20181

Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

Eric Chun Yet Lian, Andreas G. Tzakis, David Andrews

Pathology

Research output: Contribution to journal › Article

24 Scopus citations

Abstract

A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m² rituximab.

Original language	English (US)
Pages (from-to)	363-365
Number of pages	3
Journal	American Journal of Hematology
Volume	77
Issue number	4
DOIs	https://doi.org/10.1002/ajh.20181
State	Published - Dec 1 2004

Fingerprint

Keywords

Factor V inhibitor
Primary biliary cirrhosis
Rituximab
Sjögren's syndrome
Systemic lupus erythematosus

ASJC Scopus subject areas

Hematology

Cite this

Lian, E. C. Y., Tzakis, A. G., & Andrews, D. (2004). Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis. American Journal of Hematology, 77(4), 363-365. https://doi.org/10.1002/ajh.20181

@article{dd024b8ae9cd4419808bdb6fc5459dc8,

title = "Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis",

abstract = "A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sj{\"o}gren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.",

keywords = "Factor V inhibitor, Primary biliary cirrhosis, Rituximab, Sj{\"o}gren's syndrome, Systemic lupus erythematosus",

author = "Lian, {Eric Chun Yet} and Tzakis, {Andreas G.} and David Andrews",

year = "2004",

month = dec,

day = "1",

doi = "10.1002/ajh.20181",

language = "English (US)",

volume = "77",

pages = "363--365",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis

AU - Lian, Eric Chun Yet

AU - Tzakis, Andreas G.

AU - Andrews, David

PY - 2004/12/1

Y1 - 2004/12/1

N2 - A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.

AB - A 43-year-old patient developed factor V inhibitor 6 months after liver transplantation for primary biliary cirrhosis in association with Sjögren's syndrome/systemic lupus erythematosus. She suffered from ecchymoses in the lower extremities. The factor V inhibitor was eradicated after 10 weekly doses of 375-500 mg/m2 rituximab.

KW - Factor V inhibitor

KW - Primary biliary cirrhosis

KW - Rituximab

KW - Sjögren's syndrome

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=9644299781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644299781&partnerID=8YFLogxK

U2 - 10.1002/ajh.20181

DO - 10.1002/ajh.20181

M3 - Article

C2 - 15551286

AN - SCOPUS:9644299781

VL - 77

SP - 363

EP - 365

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -

Access to Document

10.1002/ajh.20181